Author:
Zhang Huijun,Zhang Xing-Quan,Huang Lina S.,Fang Xiong,Khan Mohsin,Xu Yan,An Jing,Schooley Robert T.,Huang Ziwei
Funder
University of California, San Diego
Reference46 articles.
1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome;Choo;Science,1989
2. Global elimination of hepatitis C virus infection: progresses and the remaining challenges;Taherkhani;World J. Hepatol.,2017
3. Is global elimination of HCV realistic?;Calvaruso;Liver Int.,2018
4. The combination of Grazoprevir, a hepatitis C virus (HCV) NS3/4A protease inhibitor, and Elbasvir, an HCV NS5A inhibitor, demonstrates a high genetic barrier to resistance in HCV genotype 1a replicons;Lahser;Antimicrob. Agents Chemother.,2016
5. Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitors;Wyles;Antimicrob. Agents Chemother.,2008